NASDAQ:ALGN - Align Technology Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$362.28 -1.17 (-0.32 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$363.45
Today's Range$358.02 - $366.32
52-Week Range$154.90 - $371.55
Volume400,000 shs
Average Volume1.05 million shs
Market Capitalization$29.13 billion
P/E Ratio92.55
Dividend YieldN/A
Beta1.57
Align Technology logoAlign Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases. It also provides Invisalign Express (10 and 5) and Invisalign Lite/i7 treatments for orthodontic cases, non-comprehensive treatment relapse cases, or straightening prior to restorative or cosmetic treatments; Invisalign Go, a solution for general practitioner dentists (GPs) to identify and treat patients with mild malocclusion; SmileDirectClub aligners for minor tooth movement; custom clear aligner retainers used to maintain tooth position and correct minor relapse; and SmartTrack, a custom-engineered material that delivers force for orthodontic tooth movements. The company's Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; and Restorative software for iTero, a software for GPs, prosthodontists, periodontists, and oral surgeons. It also provides Orthodontic software for iTero, a software for orthodontists for digital records storage, orthodontic diagnosis, Invisalign digital impression submission, and for the fabrication of printed models and retainers; CAD/CAM services, such as iTero Models and Dies, OrthoCAD iCast, and OrthoCAD iRecord; and Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner, as well as third party scanners and digital scans for Invisalign treatment submission. The company was founded in 1997 and is headquartered in San Jose, California.

Receive ALGN News and Ratings via Email

Sign-up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-470-1000

Debt

Debt-to-Equity RatioN/A
Current Ratio2.26
Quick Ratio2.19

Price-To-Earnings

Trailing P/E Ratio92.55
Forward P/E Ratio75.79
P/E Growth2.68

Sales & Book Value

Annual Sales$1.47 billion
Price / Sales19.71
Cash Flow$4.4229 per share
Price / Cash81.91
Book Value$14.35 per share
Price / Book25.25

Profitability

EPS (Most Recent Fiscal Year)$3.89
Net Income$231.41 million
Net Margins16.12%
Return on Equity30.36%
Return on Assets20.24%

Miscellaneous

Employees8,715
Outstanding Shares80,150,000
Market Cap$29,130.52

The Truth About Cryptocurrencies

Align Technology (NASDAQ:ALGN) Frequently Asked Questions

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.17 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.98 by $0.19. The medical equipment provider earned $436.92 million during the quarter, compared to analyst estimates of $408.27 million. Align Technology had a net margin of 16.12% and a return on equity of 30.36%. The company's revenue was up 40.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 earnings per share. View Align Technology's Earnings History.

When is Align Technology's next earnings date?

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Align Technology.

What guidance has Align Technology issued on next quarter's earnings?

Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.

What price target have analysts set for ALGN?

15 analysts have issued 12 month price objectives for Align Technology's shares. Their predictions range from $210.00 to $430.00. On average, they expect Align Technology's stock price to reach $330.00 in the next twelve months. This suggests that the stock has a possible downside of 8.9%. View Analyst Ratings for Align Technology.

What is the consensus analysts' recommendation for Align Technology?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Align Technology's key competitors?

Who are Align Technology's key executives?

Align Technology's management team includes the folowing people:
  • Mr. Joseph M. Hogan, Pres, CEO & Director (Age 61)
  • Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 51)
  • Mr. Raphael S. Pascaud, Chief Marketing Portfolio & Bus. Devel. Officer and Sr. VP of iTero Scanner & Services (Age 46)
  • Mr. Stuart Hockridge, Sr. VP of Global HR (Age 46)
  • Mr. Emory M. Wright, Sr. VP of Global Operations (Age 48)

Has Align Technology been receiving favorable news coverage?

Media stories about ALGN stock have been trending somewhat negative recently, Accern Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Align Technology earned a news sentiment score of -0.06 on Accern's scale. They also gave news articles about the medical equipment provider an impact score of 47.53 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a number of of retail and institutional investors. Top institutional investors include Rathbone Brothers plc (0.27%), Bank of Montreal Can (0.19%), Scout Investments Inc. (0.15%), Fisher Asset Management LLC (0.08%), Gateway Investment Advisers LLC (0.07%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.

Which institutional investors are selling Align Technology stock?

ALGN stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Rathbone Brothers plc, Fisher Asset Management LLC, Gateway Investment Advisers LLC, DnB Asset Management AS, CenturyLink Investment Management Co, Mckinley Capital Management LLC Delaware and Cim LLC. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.

Which institutional investors are buying Align Technology stock?

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., Bank of Montreal Can, Confluence Investment Management LLC, IFM Investors Pty Ltd, Clinton Group Inc., Atria Investments LLC, First Citizens Bank & Trust Co. and State of Alaska Department of Revenue. View Insider Buying and Selling for Align Technology.

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $362.28.

How big of a company is Align Technology?

Align Technology has a market capitalization of $29.13 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.

How can I contact Align Technology?

Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]


MarketBeat Community Rating for Align Technology (NASDAQ ALGN)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  477 (Vote Outperform)
Underperform Votes:  267 (Vote Underperform)
Total Votes:  744
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe ALGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.